Literature DB >> 21872756

Embryonic stem cells and iPS cells: sources and characteristics.

Catherine H Hackett1, Lisa A Fortier.   

Abstract

The field of regenerative medicine research is rapidly expanding. One area of interest to equine researchers is the possibility of isolating or generating pluripotent cells, capable of producing differentiated cell types derived from all 3 primary germ layers. Reports of equine embryonic stem-like (ES) cell isolation can be found in the literature. Other groups are working to produce equine-induced pluripotent stem (iPS) cells. This article summarizes the essential features needed to characterize a cell type as pluripotent, specific challenges in using the horse as a model organism for pluripotent cell generation, and current and upcoming clinical trials using ES/iPS cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21872756      PMCID: PMC3479634          DOI: 10.1016/j.cveq.2011.04.003

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  34 in total

1.  Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro.

Authors:  Shigeo Saito; Hideyo Ugai; Ken Sawai; Yusuke Yamamoto; Akira Minamihashi; Kahori Kurosaka; Yoshiro Kobayashi; Takehide Murata; Yuichi Obata; Kazunari Yokoyama
Journal:  FEBS Lett       Date:  2002-11-20       Impact factor: 4.124

2.  Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.

Authors:  H Niwa; J Miyazaki; A G Smith
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

3.  Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.

Authors:  D J Guest; M R W Smith; W R Allen
Journal:  Equine Vet J       Date:  2010-10       Impact factor: 2.888

4.  Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors:  Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal:  Cell Stem Cell       Date:  2011-01-07       Impact factor: 24.633

5.  Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.

Authors:  Ivan Gutierrez-Aranda; Veronica Ramos-Mejia; Clara Bueno; Martin Munoz-Lopez; Pedro J Real; Angela Mácia; Laura Sanchez; Gertrudis Ligero; Jose L Garcia-Parez; Pablo Menendez
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

Review 6.  Equine embryos and embryonic stem cells: defining reliable markers of pluripotency.

Authors:  D B B P Paris; T A E Stout
Journal:  Theriogenology       Date:  2010-01-13       Impact factor: 2.740

7.  Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.

Authors:  Atsushi Kunisato; Mariko Wakatsuki; Yuuki Kodama; Haruna Shinba; Isao Ishida; Kenji Nagao
Journal:  Stem Cells Dev       Date:  2010-02       Impact factor: 3.272

8.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Authors:  Luigi Warren; Philip D Manos; Tim Ahfeldt; Yuin-Han Loh; Hu Li; Frank Lau; Wataru Ebina; Pankaj K Mandal; Zachary D Smith; Alexander Meissner; George Q Daley; Andrew S Brack; James J Collins; Chad Cowan; Thorsten M Schlaeger; Derrick J Rossi
Journal:  Cell Stem Cell       Date:  2010-09-30       Impact factor: 24.633

9.  Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.

Authors:  Ashlee E Watts; Amy E Yeager; Oleg V Kopyov; Alan J Nixon
Journal:  Stem Cell Res Ther       Date:  2011-01-27       Impact factor: 6.832

10.  Induced pluripotent stem cell lines derived from equine fibroblasts.

Authors:  Kristina Nagy; Hoon-Ki Sung; Puzheng Zhang; Simon Laflamme; Patrick Vincent; Siamak Agha-Mohammadi; Knut Woltjen; Claudio Monetti; Iacovos Prodromos Michael; Lawrence Charles Smith; Andras Nagy
Journal:  Stem Cell Rev Rep       Date:  2011-09       Impact factor: 5.739

View more
  4 in total

1.  The promise of stem cell technology.

Authors:  Carlton Gyles
Journal:  Can Vet J       Date:  2012-10       Impact factor: 1.008

Review 2.  Current research on pharmacologic and regenerative therapies for osteoarthritis.

Authors:  Wei Zhang; Hongwei Ouyang; Crispin R Dass; Jiake Xu
Journal:  Bone Res       Date:  2016-03-01       Impact factor: 13.567

Review 3.  Stem Cells in Dentistry: Types of Intra- and Extraoral Tissue-Derived Stem Cells and Clinical Applications.

Authors:  Ana Gomes Paz; Hassan Maghaireh; Francesco Guido Mangano
Journal:  Stem Cells Int       Date:  2018-07-02       Impact factor: 5.443

4.  Rat-Induced Pluripotent Stem Cells-Derived Cardiac Myocytes in a Cell Culture Dish.

Authors:  Fatima Bianca A Dessouki; Pawan K Singal; Dinender K Singla
Journal:  Methods Mol Biol       Date:  2022
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.